These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 10440924)
1. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1. Dierov J; Prosniak M; Gallia G; Gartenhaus RB J Cell Biochem; 1999 Sep; 74(4):544-50. PubMed ID: 10440924 [TBL] [Abstract][Full Text] [Related]
2. Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Hiyama H; Iavarone A; LaBaer J; Reeves SA Oncogene; 1997 May; 14(21):2533-42. PubMed ID: 9191053 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
4. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577 [TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase. Wang QM; Luo X; Kheir A; Coffman FD; Studzinski GP Oncogene; 1998 May; 16(21):2729-37. PubMed ID: 9652739 [TBL] [Abstract][Full Text] [Related]
6. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
7. Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells. Sweeney KJ; Swarbrick A; Sutherland RL; Musgrove EA Oncogene; 1998 Jun; 16(22):2865-78. PubMed ID: 9671407 [TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event. Zancai P; Cariati R; Rizzo S; Boiocchi M; Dolcetti R Oncogene; 1998 Oct; 17(14):1827-36. PubMed ID: 9778049 [TBL] [Abstract][Full Text] [Related]
9. Loss of p27Kip1 from cyclin E/cyclin-dependent kinase (CDK) 2 but not from cyclin D1/CDK4 complexes in cells transformed by polyamine biosynthetic enzymes. Ravanko K; Järvinen K; Paasinen-Sohns A; Hölttä E Cancer Res; 2000 Sep; 60(18):5244-53. PubMed ID: 11016654 [TBL] [Abstract][Full Text] [Related]
10. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Greider C; Chattopadhyay A; Parkhurst C; Yang E Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213 [TBL] [Abstract][Full Text] [Related]
11. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA; DeLorenzo RJ; Tombes RM Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994 [TBL] [Abstract][Full Text] [Related]
12. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197 [TBL] [Abstract][Full Text] [Related]
13. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
14. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of Hsp90 function by ansamycins causes retinoblastoma gene product-dependent G1 arrest. Srethapakdi M; Liu F; Tavorath R; Rosen N Cancer Res; 2000 Jul; 60(14):3940-6. PubMed ID: 10919672 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Yu B; Lane ME; Pestell RG; Albanese C; Wadler S Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757 [TBL] [Abstract][Full Text] [Related]
17. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461 [TBL] [Abstract][Full Text] [Related]
19. Expression and stabilization of the MCT-1 protein by DNA damaging agents. Herbert GB; Shi B; Gartenhaus RB Oncogene; 2001 Oct; 20(46):6777-83. PubMed ID: 11709712 [TBL] [Abstract][Full Text] [Related]
20. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Tomida A; Suzuki H; Kim HD; Tsuruo T Oncogene; 1996 Dec; 13(12):2699-705. PubMed ID: 9000144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]